Targeting the apoptosome for cancer therapy
Elizabeth C Ledgerwood1, Ian M Morison
1Department of Biochemistry, University of Otago, Dunedin, New Zealand. liz.ledgerwood@otago.ac.nz
Summary
Apoptosis, a programmed cell death, is crucial for development. Understanding the apoptosome pathway is key to triggering cancer cell death and developing new cancer treatments.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Apoptosis is a programmed cell death mechanism vital for metazoan development and tissue homeostasis.
- In cancer, evasion of apoptosis promotes tumor cell survival, making targeted apoptosis induction a critical therapeutic goal.
Purpose of the Study:
- To review the mechanisms of apoptosome assembly and activation.
- To explore the regulation of these processes and their role in cancer development.
- To discuss novel therapeutic strategies targeting the apoptosome pathway.
Main Methods:
- Review of existing literature on apoptosis, the intrinsic pathway, and the apoptosome.
- Analysis of evidence linking apoptosome pathway dysfunction to cancer.
- Discussion of recent findings on tumor cell sensitivity to cytochrome c-induced apoptosis.
Main Results:
- The intrinsic apoptosis pathway, involving mitochondria and cytochrome c, culminates in apoptosome formation and caspase activation.
- Loss-of-function in the apoptosome pathway is implicated in the development of certain cancers.
- Some tumor cells exhibit heightened sensitivity to cytochrome c-induced apoptosis.
Conclusions:
- The apoptosome pathway is a critical regulator of programmed cell death.
- Dysregulation of this pathway contributes to oncogenesis.
- Targeting apoptosome-catalyzed caspase activation presents a promising avenue for novel cancer therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.

